InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (1 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Nuzum Charles Lee Sr, Director. Insider active across 1 company, notably Predictive Oncology Inc.. In total, 17 filings have been recorded. Breakdown: 1 buy · 1 sell. Total volume traded: €88k. History available since 1 July 2021. The latest transaction was filed on 5 April 2024 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations17 total
3,268 shares0Common StockSEC:0001171843-24-002002:0
2,605 shares0Common StockSEC:0001171843-23-006094:0
10,000 shares@ US$3.038732.8% of flowCommon StockSEC:0001171843-23-005886:0
3,773 shares0Common StockSEC:0001171843-23-004329:0
25,499 shares0Common StockSEC:0001415889-23-006246:0
53,539 shares0Common StockSEC:0001415889-23-001606:0
172,150 shares0Common StockSEC:0001415889-23-000210:0
23,147 shares0Common StockSEC:0001415889-22-010316:0
44,704 shares0Common StockSEC:0001415889-22-007304:0
200,000 shares@ US$0.3116100.0% of flowCommon StockSEC:0001415889-22-005366:0
Ideal exit: 14 Feb 2023 (T+270)
8,530 shares0Common StockSEC:0001415889-22-003763:0
43,775 shares0Common StockSEC:0001179110-22-000322:0
43,775 shares0Common StockSEC:0001179110-22-000322
6,265 shares0Common StockSEC:0001179110-21-009255
6,265 shares0Common StockSEC:0001179110-21-009255:0
13,995 shares0Common StockSEC:0001179110-21-007415:0
13,995 shares0Common StockSEC:0001179110-21-007415
17 of 17 declarations
About Nuzum Charles Lee Sr
Charles Lee Nuzum Sr. is a Board Member of Predictive Oncology Inc. As a board member, he participates in the governance of the company and strategic decision-making. Predictive Oncology Inc. specializes in data analytics and biopharmaceuticals. Charles leverages his experience to help guide the company's direction and enhance its market performance.
